Foresite Capital Management II’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-253,698
| Closed | -$3.43M | – | 6 |
|
|
2020
Q1 | $3.43M | Sell |
253,698
-1,419,016
| -85% | -$19.2M | 0.8% | 4 |
|
|
2019
Q4 | $40.4M | Hold |
1,672,714
| – | – | 6.66% | 2 |
|
|
2019
Q3 | $32.2M | Hold |
1,672,714
| – | – | 6.8% | 3 |
|
|
2019
Q2 | $49.4M | Hold |
1,672,714
| – | – | 27.79% | 2 |
|
|
2019
Q1 | $79.5M | Hold |
1,672,714
| – | – | 35.87% | 1 |
|
|
2018
Q4 | $60.4M | Buy |
1,672,714
+207,965
| +14% | +$7.51M | 32% | 2 |
|
|
2018
Q3 | $90.2M | Hold |
1,464,749
| – | – | 33.37% | 1 |
|
|
2018
Q2 | $98.9M | Sell |
1,464,749
-207,965
| -12% | -$14M | 34.86% | 1 |
|
|
2018
Q1 | $90.7M | Hold |
1,672,714
| – | – | 30.19% | 2 |
|
|
2017
Q4 | $99.9M | Hold |
1,672,714
| – | – | 34.92% | 2 |
|
|
2017
Q3 | $81.3M | Hold |
1,672,714
| – | – | 32.95% | 2 |
|
|
2017
Q2 | $87.9M | Buy |
1,672,714
+99,688
| +6% | +$5.24M | 40.27% | 1 |
|
|
2017
Q1 | $71.3M | Sell |
1,573,026
-1,723
| -0.1% | -$78.1K | 30.6% | 2 |
|
|
2016
Q4 | $59.6M | Sell |
1,574,749
-97,965
| -6% | -$3.71M | 29.91% | 2 |
|
|
2016
Q3 | $63.1M | Buy |
1,672,714
+697,429
| +72% | +$26.3M | 30.14% | 1 |
|
|
2016
Q2 | $17.2M | Buy |
975,285
+25,913
| +3% | +$456K | 11.73% | 3 |
|
|
2016
Q1 | $11.5M | Buy |
949,372
+211,011
| +29% | +$2.57M | 5.65% | 8 |
|
|
2015
Q4 | $18M | Sell |
738,361
-167,956
| -19% | -$4.09M | 6.03% | 6 |
|
|
2015
Q3 | $16.1M | Buy |
906,317
+101,100
| +13% | +$1.79M | 4.88% | 6 |
|
|
2015
Q2 | $14.2M | Buy |
805,217
+595,150
| +283% | +$10.5M | 4.99% | 8 |
|
|
2015
Q1 | $6.58M | Sell |
210,067
-10,000
| -5% | -$313K | 3.9% | 6 |
|
|
2014
Q4 | $6.42M | Buy |
+220,067
| New | +$6.42M | 4.4% | 7 |
|